BUPROPION HYDROCHLORIDE
- Product NDC
- 61919-136
- 11-digit product format
- 619190136
- Labeler code
- 61919
- Product ID
- 61919-136_dd2b07ad-bd69-ee94-e053-2a95a90a0bb5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPROPION HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA075932
- Marketing category
- ANDA
- Marketing start
- 2017-07-17
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-136-30 | BUPROPION HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 7 |
| 61919-136-60 | BUPROPION HYDROCHLORIDE | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-136 | BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [DIRECT_RX] | 7 | Legacy NDC, 2 package rows | 20220422_54874d2d-2b13-20d9-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-136-30 | 61919013630 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-136-30) | 2019-09-18 | 0000-00-00 | No | No | Current |
| 61919-136-60 | 61919013660 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-136-60) | 2017-07-17 | 0000-00-00 | No | No | Current |